Blood Preparation Market by Product Type (Whole Blood, Blood Components, Blood Derivatives), Application (Therapeutic Applications, Diagnostic Applications), End-User (Hospitals, Diagnostic Laboratories, Ambulatory Surgical Centers, Blood Banks), and Region; Global Insights & Forecast (2024 – 2030)

As per Intent Market Research, the Blood Preparation Market was valued at USD 23.5 billion in 2023 and will surpass USD 37.4 billion by 2030; growing at a CAGR of 6.9% during 2024 - 2030. The global blood preparation market has witnessed significant advancements in recent years, driven by a surge in demand for transfusion products, diagnostic applications, and treatments for hematological disorders. This market plays a pivotal role in healthcare by supplying essential blood components and derivatives for various medical procedures, from treating life-threatening conditions to aiding in diagnostic assessments. The growing prevalence of chronic diseases, trauma cases, and advancements in processing technologies continue to propel the market forward. Blood Components Segment Is Largest Owing to High Clinical Utilization Blood components, including red blood cells (RBCs), platelets, plasma, and white blood cells (WBCs), dominate the market due to their extensive use in a wide array of therapeutic applications. RBCs, in particular, are in high demand for treating anemia and surgical blood loss, making them a cornerstone of modern transfusion medicine. Additionally, platelets are indispensable for managing bleeding disorders, while plasma is critical for treating clotting deficiencies. The rising global burden of chronic diseases such as anemia and cancer has elevated the need for regular transfusion therapies. Technological advancements in blood component separation and storage, including pathogen reduction systems, further support the growth of this segment, ensuring safer and more efficient blood usage. Diagnostic Applications Segment Is Fastest Growing Owing to Increasing Focus on Preventive Healthcare The diagnostic applications segment is experiencing robust growth due to the increasing emphasis on early disease detection and preventive healthcare. Blood tests are essential in diagnosing conditions ranging from infections and autoimmune disorders to cancer and cardiovascular diseases. Innovations in diagnostic tools, such as advanced biomarker identification and next-generation sequencing, are driving demand for high-quality blood samples. Furthermore, the growing availability of point-of-care testing devices enhances accessibility and speed, contributing to the segment's expansion. The shift towards precision medicine and personalized healthcare solutions further underscores the importance of diagnostics in this market. Hospitals Segment Is Largest Owing to Extensive Patient Care Infrastructure Hospitals represent the largest end-user segment in the blood preparation market due to their comprehensive infrastructure for blood collection, processing, and transfusion. They cater to a diverse patient population, managing conditions such as anemia, trauma, and hemophilia, which often require immediate blood transfusions. Moreover, hospitals often serve as centralized hubs for therapeutic and diagnostic services, offering state-of-the-art equipment and specialized medical expertise. The integration of advanced blood preparation and storage technologies into hospital settings has further strengthened their role in this market. Blood Banks Segment Is Fastest Growing Owing to Rising Donation Awareness Blood banks are emerging as the fastest-growing end-user segment, driven by increased awareness about blood donation and enhanced governmental and non-governmental support for blood donation programs. Blood banks play a crucial role in ensuring a steady supply of high-quality blood and components to meet the rising demand. Efforts to improve donor recruitment and retention, along with the adoption of automated blood collection and processing systems, are propelling the growth of this segment. Additionally, advancements in cold chain logistics and inventory management are enabling blood banks to operate more efficiently, even in resource-limited settings. Therapeutic Applications Segment Is Largest Owing to Increasing Chronic Disease Prevalence Therapeutic applications, including anemia treatment, surgery, hemophilia management, and trauma care, constitute the largest application segment in the market. Anemia remains a leading driver, with millions of patients worldwide requiring regular blood transfusions. Additionally, the growing number of surgical procedures and trauma cases globally underscores the demand for therapeutic blood products. The introduction of advanced treatments, such as recombinant clotting factors for hemophilia, complements the usage of traditional blood products, further fueling the therapeutic applications segment. Enhanced patient care protocols and increased healthcare access are also key contributors to this segment's prominence. North America Is Largest Owing to Advanced Healthcare Infrastructure North America holds the largest share in the blood preparation market, underpinned by its well-established healthcare infrastructure, robust blood donation programs, and widespread adoption of advanced medical technologies. The presence of key market players and significant investments in R&D for blood processing further bolster the region's dominance. Government initiatives to enhance blood safety, such as implementing pathogen reduction technologies and promoting voluntary blood donation, also contribute to market growth. The region’s proactive approach towards chronic disease management ensures a sustained demand for blood components and derivatives. Competitive Landscape The blood preparation market is highly competitive, with key players such as Terumo Corporation, Haemonetics Corporation, and Grifols, S.A. leading the space. These companies continuously invest in R&D to develop innovative products, such as advanced blood bags and pathogen reduction systems, to maintain their market position. Collaborations, mergers, and acquisitions are common strategies adopted by industry leaders to expand their geographic presence and product portfolios. With a growing focus on safety and efficiency in blood preparation, the market is poised for significant innovation, ensuring better healthcare outcomes worldwide. Recent Developments: • Terumo Corporation launched an advanced blood bag system designed to optimize platelet storage and improve shelf life. • Grifols, S.A. completed the acquisition of a plasma collection company to expand its global plasma supply network. • CSL Behring announced regulatory approval for a new immunoglobulin therapy for primary immune deficiencies. • Haemonetics Corporation partnered with a leading healthcare provider to deploy automated blood processing systems across multiple hospitals. • Fresenius Kabi introduced an innovative transfusion management software aimed at improving blood utilization efficiency. List of Leading Companies: • Terumo Corporation • Haemonetics Corporation • Grifols, S.A. • CSL Behring • Macopharma SA • Fresenius Kabi • Baxter International Inc. • Octapharma AG • B. Braun Melsungen AG • Immucor, Inc. • Abbott Laboratories • Ortho Clinical Diagnostics • Beckman Coulter (Danaher Corporation) • Kawasumi Laboratories • Kedrion Biopharma Report Scope: Report Features Description Market Size (2023) USD 23.5 Billion Forecasted Value (2030) USD 37.4 Billion CAGR (2024 – 2030) 6.9% Base Year for Estimation 2023 Historic Year 2022 Forecast Period 2024 – 2030 Report Coverage Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments Segments Covered Blood Preparation Market by Product Type (Whole Blood, Blood Components, Blood Derivatives), Application (Therapeutic Applications, Diagnostic Applications), End-User (Hospitals, Diagnostic Laboratories, Ambulatory Surgical Centers, Blood Banks) Regional Analysis North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa) Major Companies Terumo Corporation, Haemonetics Corporation, Grifols, S.A., CSL Behring, Macopharma SA, Fresenius Kabi, Baxter International Inc., Octapharma AG, B. Braun Melsungen AG, Immucor, Inc., Abbott Laboratories, Ortho Clinical Diagnostics, Beckman Coulter (Danaher Corporation), Kawasumi Laboratories, Kedrion Biopharma Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements